The gene and cell therapy industry has significant potential. But this will only be realised if manufacturers share information about their technologies, enabling the advanced therapies to be produced at scale and marketed at affordable prices. ---Subscribe to MedNous to access this article--- Clinical Research Regenerative Medicine Company News Regulation & Policy
